Literature DB >> 12136912

Controversies in COX-2 selective inhibition.

Lee S Simon1, Josef S Smolen, Steven B Abramson, Gerald Appel, Claire Bombardier, D Craig Brater, Ferdinand C Breedveld, K Brune, Gerd R Burmester, Leslie J Crofford, Maxime Dougados, Raymond N DuBois, Garret A Fitzgerald, W Frishman, Luis A García Rodríguez, Marc C Hochberg, Joachim R Kalden, Loren Laine, Michael J S Langman, Stephen M Prescott, Leo B A van de Putte, Andrew Whelton, William B White, Gordon H Willaims.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12136912

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

1.  The renal effects of the addition of low-dose aspirin to COX-2 selective and nonselective antiinflammatory drugs.

Authors:  Omer Nuri Pamuk; Necati Cakir
Journal:  Clin Rheumatol       Date:  2005-09-21       Impact factor: 2.980

2.  Treatment strategies for osteoarthritis patients with pain and hypertension.

Authors:  Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Paola Martire; Marta Garofoli; Giorgio Gentile; Gianpaolo Reboldi
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

Review 3.  Cardiovascular risk, hypertension, and NSAIDs.

Authors:  William B White
Journal:  Curr Rheumatol Rep       Date:  2007-04       Impact factor: 4.592

4.  COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients.

Authors:  Marc C Hochberg
Journal:  Arthritis Res Ther       Date:  2002-12-11       Impact factor: 5.156

Review 5.  Cardiovascular risk, hypertension, and NSAIDs.

Authors:  William B White
Journal:  Curr Pain Headache Rep       Date:  2007-12

6.  Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635].

Authors:  Malcolm Doupe; Alan Katz; Brent Kvern; Lori-Jean Manness; Colleen Metge; Glen T D Thomson; Laura Morrison; Kat Rother
Journal:  BMC Health Serv Res       Date:  2004-08-24       Impact factor: 2.655
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.